Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- WIT +4.7%, BFLY +3.7% (guidance), BBCP +3.1%, VLRS +2.3% (guidance), JPM +1.7%, BK +0.6%
Other news:
- SLDB +6.8% (FDA grants orphan designations for treatment of duchenne muscular dystrophy)
- IFF +4.7% (appoints new CEO reiterates guidance; also upgraded to Buy from Hold at Jefferies)
- HSHP +2.8% (achieved average time charter equivalent earnings of ~ $34900 per day gross in December)
- CIVI +1.8% (Vencer Energy Holdings discloses 7.1% passive stake)
- EQT +1.6% (Heads of Agreement for liquefaction services)
- EOG +1.6% (anticipates a Q4 net gain of $298 million on the mark-to-market of its financial commodity derivative contracts)
- CPA +1.3% (December traffic data)
- ESPR +1.3% (issues prelim FY24 OpEx) .
Analyst comments:
- PBPB +4% (upgraded to Buy from Hold at The Benchmark Company)
- PEGA +3.3% (upgraded to Equal Weight from Underweight at Barclays)
- CIEN +1.8% (upgraded to Outperform from In-line at Evercore ISI)
- QCOM +1.8% (upgraded to Buy from Neutral at Citigroup)
- TWLO +1.7% (upgraded to Overweight from Neutral at Piper Sandler)